Systemic Drug Treatment in Dermatology: A HandbookSarah H. Wakelin, Howard I. Maibach, Clive B. Archer CRC Press, 1 Haz 2002 - 256 sayfa There has been an increase in the use of systemic drug therapy for skin diseases during recent years. This reflects advances in drug development but many are potent drugs which can have serious or life threatening adverse effects. Aimed at dermatologists and general practitioners, this book provides an accessible and concise aid to prescribing and |
İçindekiler
PREFACE | 4 |
CONTRIBUTORS | 5 |
ABBREVIATIONS | 8 |
ACITRETIN | 9 |
ACNE ANTIBIOTICS | 17 |
ANDROGENS | 25 |
ANTIANDROGENS | 32 |
ANTIFUNGALS | 41 |
HYDROXYUREA | 138 |
INTERFERONS | 145 |
INTRAVENOUS IMMUNOGLOBULIN IVIg | 155 |
ISOTRETINOIN | 162 |
METHOTREXATE | 172 |
MYCOPHENOLATE MOFETIL | 182 |
NICOTINAMIDE | 187 |
PSORALENS | 191 |
ANTIHISTAMINES | 64 |
ANTIMALARIALS | 74 |
AZATHIOPRINE | 81 |
CICLOSPORIN CYCLOSPORIN | 89 |
CLOFAZIMINE | 99 |
COLCHICINE | 103 |
CYCLOPHOSPHAMIDE | 108 |
DAPSONE | 114 |
FUMARIC ACID ESTERS | 120 |
GLUCOCORTICOSTEROIDS | 126 |
SULPHAPYRIDINE and SULPHAMETHOXYPYRIDAZINE | 201 |
THALIDOMIDE | 209 |
TREATMENT IN PREGNANCY AND LACTATION | 215 |
TREATMENT IN CHILDHOOD | 223 |
TREATMENT IN PATIENTS WITH RENAL DISEASE | 233 |
TREATMENT IN PATIENTS WITH LIVER DISEASE | 242 |
APPENDIX | 250 |
BACK COVER | 252 |
Sık kullanılan terimler ve kelime öbekleri
abnormalities acid acitretin acne action activity administration adverse effects agents antihistamines appears associated avoided binding blood cause caution cell changes childhood chronic ciclosporin clinical combination concentrations containing continued contraception contraindicated controlled dapsone decreased dermatitis Dermatol dermatological develop dosage dose drug drug interactions excreted failure Further given glucose half-life hepatic Hospital impairment increased Indications infection inhibits interferon intravenous isotretinoin itraconazole lactation levels LFTs licensed lichen planus liver disease London long-term lupus Main mg daily mg/day mg/kg/day monitoring months normal occur once oral particularly patients plasma possible potential pregnancy prescribed Presentation psoriasis PUVA rare reactions recommended reduced References regimens renal renal function renal impairment reported response retinoids risk safety serum severe shown side-effects skin starting stopping studies suggested symptoms systemic Table tablets taking teratogenic terbinafine tests thalidomide therapy topical toxicity treated treatment usually weeks women